Astronauts predictably experience anemia after return from space. Upon ente
ring microgravity, the blood volume in the extremities pools centrally and
plasma volume decreases, causing plethora and erythropoietin suppression. T
here ensues neocytolysis, selective hemolysis of the youngest circulating r
ed cells, allowing rapid adaptation to the space environment but becoming m
aladaptive on re-entry to a gravitational field. The existence of this phys
iologic control process was confirmed in polycythemic high-altitude dweller
s transported to sea level. Pathologic neocytolysis contributes to the anem
ia of renal failure. Understanding the process has implications for optimiz
ing erythropoietin-dosing schedules and the therapy of other human disorder
s. Human and rodent models of neocytolysis are being created to help find o
ut how interactions between endothelial cells, reticuloendothelial phagocyt
es and young erythrocytes are altered, and to shed light on the expression
of surface adhesion molecules underlying this process. Thus, unraveling a p
roblem for space travelers has uncovered a physiologic process controlling
the red cell mass that can be applied to human disorders on Earth.